Filing Details
- Accession Number:
- 0000950170-24-077522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-25 20:00:30
- Reporting Period:
- 2024-06-21
- Accepted Time:
- 2024-06-25 20:00:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 873303 | Sarepta Therapeutics Inc. | SRPT | Pharmaceutical Preparations (2834) | 930797222 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1848718 | Edward Ryan Brown | 215 First Street Suite 415 Cambridge MA 02124 | Evp, General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-06-21 | 6,250 | $0.00 | 34,938 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-24 | 2,352 | $164.64 | 32,586 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2024-06-25 | 23,500 | $62.77 | 56,086 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-06-25 | 7,644 | $158.07 | 48,442 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 2,200 | $159.14 | 46,242 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 975 | $160.31 | 45,267 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 4,168 | $161.82 | 41,099 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 17,581 | $162.65 | 23,518 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 3,840 | $163.53 | 19,678 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-25 | 2,549 | $164.52 | 17,129 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Stock Units | Acquisiton | 2024-06-21 | 5,500 | $0.00 | 5,500 | $0.00 |
| Common Stock | Performance Stock Units | Acquisiton | 2024-06-21 | 6,250 | $0.00 | 6,250 | $0.00 |
| Common Stock | Performance Stock Units | Disposition | 2024-06-21 | 6,250 | $0.00 | 6,250 | $0.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-06-25 | 23,500 | $0.00 | 23,500 | $62.77 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,500 | No | 4 | A | Direct | ||
| 6,250 | No | 4 | A | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | 2019-02-28 | 2028-02-28 | No | 4 | M | Direct |
Footnotes
- Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.
- Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.58 to $158.52, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.67 to $159.66, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.71 to $160.69, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.04 to $162.02, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.12 to $163.09, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.19 to $163.98 inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.
Billionaire Hedge Funds
